Your browser doesn't support javascript.
loading
HIV Pre-Exposure Prophylaxis Uptake Among High-Risk Population in Sub-Saharan Africa: A Systematic Review and Meta-Analysis.
Nagai, Henry; Ankomah, Augustine; Fuseini, Kamil; Adiibokah, Edward; Semahegn, Agumasie; Tagoe, Henry.
Afiliação
  • Nagai H; John Snow Research and Training Institute, Inc., Accra, Ghana.
  • Ankomah A; Department of Population, Family and Reproductive Health, School of Public Health, University of Ghana, Accra, Ghana.
  • Fuseini K; Population Council, Ghana, Accra, Ghana.
  • Adiibokah E; John Snow Research and Training Institute, Inc., Accra, Ghana.
  • Semahegn A; Department of Population, Family and Reproductive Health, School of Public Health, University of Ghana, Accra, Ghana.
  • Tagoe H; College of Health and Medical Sciences, Haramaya University, Harar, Ethiopia.
AIDS Patient Care STDS ; 38(2): 70-81, 2024 Feb.
Article em En | MEDLINE | ID: mdl-38381951
ABSTRACT
Globally, 38.4 million people are affected by the human immunodeficiency virus (HIV) pandemic, and more than 2.5 million new HIV infections occur yearly. HIV pre-exposure prophylaxis (PrEP) has been widely recognized as a potential way to prevent new infections among risk population. There is a paucity of abridged evidence on the level and barriers to PrEP service uptake in sub-Saharan Africa (SSA). Therefore, we conducted a systematic review to synthesize existing evidence on PrEP uptake in SSA. Relevant studies were searched from major databases (PubMed and PsychInfo) and direct Google Scholar. Data were extracted and recorded using a pilot-tested template. Methodological rigor, heterogeneity and publication bias of studies were assessed to minimize the inclusion of erroneous findings. A random effect model was used for the meta-analysis followed by narrative metasynthesis. The protocol of this systematic review has been by registered PROSPERO (ID CRD42022308855). A total of 1830 studies were retrieved, and 30 studies met inclusion criteria of the systematic review. People who heard about PrEP ranged from 23% to 98%. The pooled prevalence of willingness to use PrEP was 64.2% (95% confidence interval 55.5-72.0). Fear of side effect, stigma, nonreceptive attitude, cost of pills, low awareness about PrEP, perceived reason about the effectiveness of PrEP, and lack of friendly services were the common barriers to PrEP uptake in Africa. In conclusion, comprehensive knowledge and willingness to use PrEP were low in SSA. The barriers to low PrEP service uptake are avoidable through comprehensive awareness creation and availing essential services to key population in Africa. Expanding educational messages to key population using friendly approaches and more accessible platforms, engaging stakeholders, and integrating PrEP service with routine health care are important to foster HIV prevention and control in the future.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Aceitação pelo Paciente de Cuidados de Saúde / Infecções por HIV / Conhecimentos, Atitudes e Prática em Saúde / Fármacos Anti-HIV / Profilaxia Pré-Exposição Limite: Adult / Female / Humans / Male País/Região como assunto: Africa Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Aceitação pelo Paciente de Cuidados de Saúde / Infecções por HIV / Conhecimentos, Atitudes e Prática em Saúde / Fármacos Anti-HIV / Profilaxia Pré-Exposição Limite: Adult / Female / Humans / Male País/Região como assunto: Africa Idioma: En Ano de publicação: 2024 Tipo de documento: Article